Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial - The Lancet Infectious Diseases
Pfizer (PFE), Moderna (MRNA) Covid Booster Vaccines Greenlighted by CDC Panel - Bloomberg
More adverse reactions following bivalent COVID-19 mRNA booster vaccine
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Bivalent mRNA booster effective, 'essential' for older adults
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults - The Lancet Infectious Diseases
Moderna on X: "A 50 µg #booster dose of our first bivalent booster #vaccine candidate, mRNA-1273.211, demonstrated superiority against Beta, Delta and #Omicron variants of concern one month after administration, and superiority
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Vaccines | Free Full-Text | Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
CDC on X: "CDC recommends Novavax's non-mRNA booster for people ages 18+, for certain situations. This includes those unable or unwilling to receive mRNA #COVID19 vaccines. The Novavax COVID-19 booster targets the
RACGP - Four things about mRNA vaccines researchers still want to find out
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa: Molecular Therapy
